Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
0.7897
-0.0319 (-3.88%)
May 6, 2025, 4:00 PM EDT - Market closed

Prelude Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Market Capitalization
45702682875773,033
Upgrade
Market Cap Growth
-83.72%-73.80%-6.83%-50.21%-80.97%-
Upgrade
Enterprise Value
-71-6538652592,798
Upgrade
Last Close Price
0.821.274.276.0412.4571.55
Upgrade
PS Ratio
8.9010.02----
Upgrade
PB Ratio
0.340.531.131.472.0214.30
Upgrade
P/TBV Ratio
0.340.531.131.472.0214.30
Upgrade
Debt / Equity Ratio
0.170.140.070.010.01-
Upgrade
Asset Turnover
0.040.03----
Upgrade
Quick Ratio
5.015.2110.679.3015.1719.19
Upgrade
Current Ratio
5.185.3010.799.4215.3719.41
Upgrade
Return on Equity (ROE)
-81.44%-69.01%-56.34%-47.97%-44.85%-49.67%
Upgrade
Return on Assets (ROA)
-45.05%-38.54%-33.19%-29.38%-26.89%-29.93%
Upgrade
Return on Capital (ROIC)
-50.07%-43.29%-36.64%-31.85%-28.44%-32.01%
Upgrade
Earnings Yield
-285.26%-181.24%-45.50%-40.16%-19.35%-1.88%
Upgrade
FCF Yield
-232.50%-147.72%-41.29%-30.18%-14.87%-1.54%
Upgrade
Buyback Yield / Dilution
-25.60%-25.60%-27.41%-2.87%-269.03%-647.86%
Upgrade
Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q